Ignite Creation Date:
2025-12-24 @ 9:31 PM
Ignite Modification Date:
2026-01-04 @ 5:42 AM
Study NCT ID:
NCT00658632
Status:
COMPLETED
Last Update Posted:
2016-05-04
First Post:
2008-04-09
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Rabeprazole Extended-Release 50 mg Versus Esomeprazole 40 mg for Healing and Symptomatic Relief of Mild to Moderate Erosive Gastroesophageal Reflux Disease (GERD)
Sponsor:
Eisai Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-02
Start Date Type:
None
Primary Completion Date:
2009-04
Primary Completion Date Type:
ACTUAL
Completion Date:
2009-09
Completion Date Type:
ACTUAL
First Submit Date:
2008-04-09
First Submit QC Date:
None
Study First Post Date:
2008-04-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2015-06-08
Results First Submit QC Date:
None
Results First Post Date:
2015-06-23
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-03-28
Last Update Post Date:
2016-05-04
Last Update Post Date Type:
ESTIMATED